International Institute of Cancer Immunology, Inc.
USPTO PatentsView assignee record - 43 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, International ranks #7,574 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 6 technology areas.
- #7,574
- of 49,997 US assignees by volume
- 35th percentile
- by Innovation Score (30.8/100)
- 10.3
- avg claims per patent
- -36%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R7574 · Foreign Corporation #7,574 · 43 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 43 grants
- UPPER-Q #7,574/49,997
- PHOTO-FINISH Integra LifeSciences
- CPC-NARROW C07K · 6 areas
- INNOV-THIN 30.8/100
- CLAIMS-PAR 10.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -36% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Integra LifeSciences Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How International’s 30.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around International
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Enterome · near 31
Enterome · near
31 score
- International… · this assignee 31
International… · this assignee
31 score
- Manscaped · near 31
Manscaped · near
31 score
- Zak Designs · near 31
Zak Designs · near
31 score
- American Radionic · near 31
American Radionic · near
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows International's Innovation Score is 30.8/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for International?
Each dot is one of International’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). International’s own 10.3 claims/patent is at or below the 15.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where International's grants concentrate
International Institute of Cancer Immunology, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 86% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (7 grants) versus a trough of 2 in 2022. By volume, International sits between Integrated Silicon Solution Inc. and Johnson Matthey Davy Technologies Limited.
International's three-year grant acceleration
International Institute of Cancer Immunology, Inc. shows 6 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at International's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Integrated Silico…
Integrated Silicon Solution Inc.
43 patents
- Interblock D O O
Interblock D.O.O.
43 patents
- Invently Automoti…
Invently Automotive Inc.
43 patents
- Integra Lifescien…
Integra LifeSciences Corporation
43 patents
- Inveniam Capital…
Inveniam Capital Partners, Inc.
43 patents
- Japan Petroleum E…
Japan Petroleum Exploration Co., Ltd.
43 patents
- Jiangsu Xcmg Cons…
Jiangsu Xcmg Construction Machinery Research Institute Ltd.
43 patents
- Johnson Matthey D…
Johnson Matthey Davy Technologies Limited
43 patents
- International Ins… ◀
International Institute of Cancer Immunology, Inc.
43 patents
What this shows International holds 43 patents at rank #7,575, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near International
By rank, the assignees closest to #7,575 in granted patent volume.
- Integrated Silicon Solution Inc. #7,571 · 43 patents
- Interblock D.O.O. #7,572 · 43 patents
- Invently Automotive Inc. #7,573 · 43 patents
- Integra LifeSciences Corporation #7,574 · 43 patents
- Inveniam Capital Partners, Inc. #7,576 · 43 patents
- Japan Petroleum Exploration Co., Ltd. #7,577 · 43 patents
- Jiangsu Xcmg Construction Machinery Research Institute Ltd. #7,578 · 43 patents
- Johnson Matthey Davy Technologies Limited #7,579 · 43 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in International's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for International, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), International ranks #259 of 3,615 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (31 here).
International's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 35th percentile higher than 35% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 16.3% |
| 2016 | 6 | 14.0% |
| 2017 | 5 | 11.6% |
| 2018 | 3 | 7.0% |
| 2019 | 4 | 9.3% |
| 2020 | 7 | 16.3% |
| 2021 | 3 | 7.0% |
| 2022 | 2 | 4.7% |
| 2023 | 4 | 9.3% |
| 2025partial year | 2 | 4.7% |
Which technologies does International Institute of Cancer Immunology, Inc. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
International Institute of Cancer Immunology, Inc.'s patent record in context - here's where to go next.
- International Institute of Cancer Immunology, Inc.'s lead technology class is C07K (Peptides), 86% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #7,574 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare International Institute of Cancer Immunology, Inc. against Integrated Silicon Solution Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.